Clinical Trial Update: A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)] [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the LBL-024 combination in patients with advanced solid tumours, including a sub-study in non-small cell lung cancer, is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumour

Drugs mentioned

• LBL-024

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Advanced Solid Tumour | Phase 2 | Status: RECRUITING